Two New Testosterone Formulations Flunk FDA Panel

Buy Lab Tests Online
It's a bad day for Big Pharma when it comes to new testosterone formulations. Two new drugs, Tlando and Jatenzo did not gain approval by an FDA advisory panel. Both are oral forms of testosterone undecanoate, meant to be taken daily. The two new drugs were turned down over fears of side effects on cardiovascular health and cholesterol levels. The financial press has the news:



Lipocine arrived at the FDA meeting armed with data from two phase 3 trials showing Tlando moves average serum testosterone concentrations up into the normal range in most people. That result was enough for the studies to meet their primary endpoints. But the overall dataset failed to quell fears about cardiovascular adverse events and the drug’s effect on blood pressure.

 
Buy Lab Tests Online

Sponsors

bodybuilder test discounted labs
Defy Medical TRT clinic
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me
how to save your marriage

Online statistics

Members online
3
Guests online
7
Total visitors
10

Latest posts

Top